Information Provided By:
Fly News Breaks for January 4, 2019
INFI
Jan 4, 2019 | 04:51 EDT
B. Riley FBR George Zavoico started Infinity Pharmaceuticals with a Buy rating and $3 price target. The company could "hold the key" to improving checkpoint inhibitors in cancer, Zavoico tells investors in a research note.
News For INFI From the Last 2 Days
There are no results for your query INFI